Research Development Immunotherapy connect with immunotherapy-related research and clinical trials being undertaken in other VCCC partner Immunotherapies are a new class of anti-cancer organisations to leverage the critical mass of expertise therapy that have the potential to change the way and patient numbers provided by the alliance. cancer is treated. The stated vision for the Centre for Immunotherapy This coordinated, collaborative program will grow is that within five years Victorian patients with all opportunities for multi-disciplinary clinical research types of advanced cancer will have access to a clinical in this rapidly evolving field so that ultimately trial or treatment with an appropriate immune-based more patients have the chance to benefit from cancer therapy. immunotherapy treatment. The appointment of the inaugural director will Activity to date has focussed on defining and be made in August 2018, with the centre to be finding the ideal leadership for a new Centre for operational before the end of the year. Immunotherapy, located on Level 13 of the VCCC building. The collaborative centre is a joint initiative of the VCCC alliance, Peter MacCallum Cancer Centre and the University of Melbourne. The centre will bring together Peter Mac’s experience and expertise in immunotherapy research and clinical translation with the leading immunology programs of the University of Melbourne and the Doherty Institute. It will also 43